
This is not medical advice. Consult a qualified healthcare provider before using any remedy, especially if pregnant, breastfeeding, on medication, or managing a health condition.
Devil's Claw is named for its dramatic claw-like fruit hooks that attach to passing animals for seed dispersal. Its tubers contain harpagoside, an iridoid glycoside recognized by the European Medicines Agency (EMA) for well-established use in musculoskeletal pain. Multiple RCTs demonstrate anti-inflammatory and analgesic efficacy comparable to pharmaceutical NSAIDs for back pain and osteoarthritis, with a superior GI safety profile.
Indigenous peoples of the Kalahari Desert in southern Africa (Tswana, San, Herero, and Khoi peoples) have used Devil's Claw root for pain, fever, inflammation, and digestive complaints for centuries. South African settlers adopted its use in the early 20th century, and it was introduced to European phytomedicine in the 1950s by German researcher G.H. Mehnert. European clinical research from the 1970s onward established its value as a musculoskeletal anti-inflammatory.
The primary active compound and marker for extract standardization. Inhibits COX-2 and 5-LOX (both major inflammatory pathways), iNOS synthesis, and NF-kB activation. Unlike NSAIDs (which primarily inhibit COX-1 and COX-2), harpagoside's multi-pathway inhibition may explain its superior GI tolerance.
Significant phytosterol content providing additional anti-inflammatory activity.
Multiple RCTs show significant reduction in back pain intensity and improved mobility. A Cochrane Review (2004) found Devil's Claw effective for nonspecific low back pain. Compares favorably to rofecoxib (Vioxx) in some trials with better tolerability.
Clinical trials show significant pain reduction in knee and hip osteoarthritis. EMA recognizes traditional well-established use for musculoskeletal pain with supporting clinical evidence.
The bitterness stimulates digestive function. Traditional use as a digestive tonic aligns with the bitter-stimulant mechanism.
Use standardized extract specifying harpagoside content.
Dosage: 600–2400mg daily of extract standardized to 2.5% harpagoside (or 50–100mg pure harpagoside daily)Allow 4–8 weeks for full effect. The most studied extracts are Doloteffin and WS 1531. Take with food to reduce GI effects. Minimum 4-week trial is necessary to assess response.
Simmer 4.5g of dried Devil's Claw tuber in 300ml water for 20 minutes. Strain.
Dosage: 1 cup 2–3 times dailyTraditional southern African preparation. Less standardized than extracts but contains full spectrum of compounds. Strong bitter taste.
Please read carefully before use
Cochrane Database of Systematic Reviews
Pedaliaceae
Secondary storage roots (tubers), Not the primary root or aerial parts
Intensely bitter — the iridoid glycoside harpagoside responsible for the bitterness is also responsible for the anti-inflammatory action
Always consult with a qualified healthcare provider before starting any new remedy, especially if you have existing health conditions or take medications.